epcam car-t cells
Cell therapyexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2015 (NCT02725125)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Epithelial cell adhesion moleculeImmunity, passive
EPCAM immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- epcam car-t cells
- epcam-targeted car-t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05028933 | Phase 1 | Sep 30, 2021 | Zhejiang University |
| NCT03563326 | Phase 1 | Aug 30, 2018 | Sichuan University |
| NCT02915445 | Phase 1 | Jul 1, 2016 | Sichuan University |
| NCT02729493 | N/A | Nov 14, 2015 | Sinobioway Cell Therapy Co., Ltd. |
| NCT02725125 | N/A | Nov 1, 2015 | Sinobioway Cell Therapy Co., Ltd. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sichuan University | Academic/Hospital | 2 | 2 | 1 | 2016 |
| Sinobioway Cell Therapy Co., Ltd. | For profit | 2 | 2 | 1 | 2015 |
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2021 |
3 organizations
Page 1 / 1